Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
1037O MASTERKEY-265: A phase III, randomized, placebo (Pbo)-controlled study of talimogene laherparepvec (T) plus pembrolizumab (P) for unresectable stage IIIB–IVM1c melanoma (MEL)
A. Ribas, Jason Alan Chesney, Georgina Venetia Long, John M. Kirkwood, Reinhard Dummer, Igor J. Puzanov and 14 more
- Rank
- 95 of 3,031
- Percentile
- top 3.2%
- Where
- Annals of Oncology, 2021
- Citations
- 58
From the 2021 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.